CVRX

$0.00

(

0.00%

)
Quote details

stock

CVRx Inc

NASDAQ | CVRX

9.71

USD

$0.00

(

0.00%

)

At Close (As of Nov 7, 2025)

$254.50M

Market Cap

-

P/E Ratio

-1.99

EPS

$18.55

52 Week High

$4.29

52 Week Low

HEALTHCARE

Sector

CVRX Chart

Recent Chart
Price Action

CVRX Technicals

Tags:

CVRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $43M
Total Revenue $51M
Cost Of Revenue $8.3M
Costof Goods And Services Sold $8.3M
Operating Income -$59M
Selling General And Administrative $91M
Research And Development $11M
Operating Expenses $102M
Investment Income Net -
Net Interest Income -$4.4M
Interest Income -
Interest Expense $4.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $619K
Income Before Tax -$60M
Income Tax Expense $55K
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$56M
Ebitda -$55M
Net Income -$60M

Revenue & Profitability

Earnings Performance

CVRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $133M
Total Current Assets $130M
Cash And Cash Equivalents At Carrying Value $106M
Cash And Short Term Investments $106M
Inventory $12M
Current Net Receivables $9.3M
Total Non Current Assets $3.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.5M
Other Non Current Assets -
Total Liabilities $62M
Total Current Liabilities $11M
Current Accounts Payable $2.6M
Deferred Revenue -
Current Debt -
Short Term Debt $564K
Total Non Current Liabilities $52M
Capital Lease Obligations $1.2M
Long Term Debt $49M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $50M
Other Current Liabilities $7.5M
Other Non Current Liabilities $1.4M
Total Shareholder Equity $71M
Treasury Stock -
Retained Earnings -$537M
Common Stock $253K
Common Stock Shares Outstanding $23M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$39M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $619K
Capital Expenditures $1.4M
Change In Receivables -
Change In Inventory -$1.1M
Profit Loss -
Cashflow From Investment -$1.4M
Cashflow From Financing $56M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$60M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $43M
Total Revenue $51M
Cost Of Revenue $8.3M
Costof Goods And Services Sold $8.3M
Operating Income -$59M
Selling General And Administrative $91M
Research And Development $11M
Operating Expenses $102M
Investment Income Net -
Net Interest Income -$4.4M
Interest Income -
Interest Expense $4.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $619K
Income Before Tax -$60M
Income Tax Expense $55K
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$56M
Ebitda -$55M
Net Income -$60M

CVRX News

CVRX Profile

CVRx Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

CVRx Inc. is a leading medical technology firm focused on innovative implantable devices that tackle chronic health issues, particularly hypertension and heart failure. Its flagship product, the Barostim Neo, utilizes advanced neuromodulation techniques to manage blood pressure effectively in patients who do not respond to traditional therapies. Committed to enhancing patient outcomes and addressing critical clinical needs, CVRx is strategically positioned to impact the cardiovascular sector significantly, driving advancements that expand access to vital treatments. The company's robust pipeline and dedication to innovation underscore its potential for growth and value creation within the healthcare market.

BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ACHR
-7.88%
$8.18
ASST
+4.13%
$1.51
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
ONDS
+10.66%
$5.81
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
WTO
-7.52%
$0.04
SNAP
+2.49%
$8.21
AAL
+3.80%
$13.65
BITF
-0.81%
$3.66
AXDX
-61.36%
$0.03
NIO
-4.18%
$6.86
RIVN
+0.06%
$15.23
CHR
+0.15%
$0.06
DVLT
+24.26%
$1.69
T
+0.36%
$24.83
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BURU
+3.54%
$0.28
BTG
+2.89%
$3.91
PBR
+5.93%
$12.86
IREN
-6.83%
$62.38
JOBY
+4.05%
$14.90
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
YDKG
-1.56%
$0.05
AMZN
+0.56%
$244.41
CIFR
-4.69%
$20.69
BMNR
+7.65%
$40.22
HOOD
+2.58%
$130.36
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
BTBT
+3.63%
$3.14
DKNG
+8.64%
$30.40
EOSE
+19.42%
$18.26
SMR
-6.53%
$30.34
NOK
-1.01%
$6.84
RMBL
+60.50%
$3.21
BAC
-0.16%
$53.20
ABEV
+1.25%
$2.43
RIG
+2.05%
$3.98
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
VIVK
+11.85%
$0.16
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
GOOGL
-2.07%
$278.83
TTD
-6.31%
$43.00
CMG
+0.09%
$30.59
QS
+4.52%
$16.62
ORGO
+44.73%
$5.63
IONQ
+3.20%
$59.27
SMCI
-1.42%
$39.76
FIG
-3.76%
$44.25
EPWK
+3.23%
$0.07
PLTZ
-3.51%
$6.86
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.50%
$2.40
META
+0.44%
$621.71
ELDN
-49.75%
$2.06
PTON
+14.15%
$7.66
RF
+2.22%
$24.85
IOVA
-0.43%
$2.29
MTC
-6.85%
$2.58
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
CAN
+5.30%
$1.19
VZ
+0.52%
$40.03
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
QUBT
-2.20%
$12.86
CLSK
+1.10%
$15.57
NGD
+1.58%
$7.03
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36
BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ACHR
-7.88%
$8.18
ASST
+4.13%
$1.51
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
ONDS
+10.66%
$5.81
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
WTO
-7.52%
$0.04
SNAP
+2.49%
$8.21
AAL
+3.80%
$13.65
BITF
-0.81%
$3.66
AXDX
-61.36%
$0.03
NIO
-4.18%
$6.86
RIVN
+0.06%
$15.23
CHR
+0.15%
$0.06
DVLT
+24.26%
$1.69
T
+0.36%
$24.83
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BURU
+3.54%
$0.28
BTG
+2.89%
$3.91
PBR
+5.93%
$12.86
IREN
-6.83%
$62.38
JOBY
+4.05%
$14.90
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
YDKG
-1.56%
$0.05
AMZN
+0.56%
$244.41
CIFR
-4.69%
$20.69
BMNR
+7.65%
$40.22
HOOD
+2.58%
$130.36
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
BTBT
+3.63%
$3.14
DKNG
+8.64%
$30.40
EOSE
+19.42%
$18.26
SMR
-6.53%
$30.34
NOK
-1.01%
$6.84
RMBL
+60.50%
$3.21
BAC
-0.16%
$53.20
ABEV
+1.25%
$2.43
RIG
+2.05%
$3.98
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
VIVK
+11.85%
$0.16
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
GOOGL
-2.07%
$278.83
TTD
-6.31%
$43.00
CMG
+0.09%
$30.59
QS
+4.52%
$16.62
ORGO
+44.73%
$5.63
IONQ
+3.20%
$59.27
SMCI
-1.42%
$39.76
FIG
-3.76%
$44.25
EPWK
+3.23%
$0.07
PLTZ
-3.51%
$6.86
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.50%
$2.40
META
+0.44%
$621.71
ELDN
-49.75%
$2.06
PTON
+14.15%
$7.66
RF
+2.22%
$24.85
IOVA
-0.43%
$2.29
MTC
-6.85%
$2.58
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
CAN
+5.30%
$1.19
VZ
+0.52%
$40.03
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
QUBT
-2.20%
$12.86
CLSK
+1.10%
$15.57
NGD
+1.58%
$7.03
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.